ArticleRadiological physics and technology2026
Impact of the locking function of hybrid inverse planning optimization on the treatment plan quality of intracavitary/interstitial brachytherapy for locally advanced cervical cancer.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial intelligence in radiation treatment planning: a narrative review from automation to clinical decision support.Translational cancer research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the dosimetric characteristics of intracavitary/interstitial brachytherapy (IC/ISBT) plans created via the hybrid inverse planning optimization (HIPO) algorithm with the dwell time Lock function. MATERIALS AND
methodsSixteen patients with locally advanced cervical cancer treated with high-dose-rate IC/ISBT were evaluated. Based on the clinical plan data, five plans were retrospectively created: Manchester-based HIPO for needles, HIPO for all applicators, HIPO for needles after HIPO for tandem/ovoid, HIPO for ovoid after HIPO for tandem/needle, and HIPO for ovoid/needle after HIPO for tandem. The target coverage, organs at risk (OARs) doses, therapeutic ratios, and the dwell time contributions of the needles were analyzed to evaluate the plan quality. Dice similarity coefficients (DSCs) between clinical plan and each created plan were calculated to evaluate the similarity of the shape of the dose distribution.
resultsAll plans created using HIPO had a sufficient target coverage, while the OAR dose for the Manchester-based HIPO plans was considerably higher than the other plans. The plan with HIPO for all applicators and with HIPO for the ovoid applicator after HIPO for tandem/needles had comparable or superior therapeutic ratios than those of the clinical plan while the dwell time contributions of the needle were much larger. For DSCs, an intermediate to low correlation was observed between the clinical plan and all HIPO plans.
conclusionsThe HIPO algorithm could create high-quality IC/ISBT plans, although the dosimetric consequences were affected by the locking function.
Indexed as
Identifiers
41557135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.